Notice is hereby given that the Office of Research Integrity (ORI) has made a final finding of scientific misconduct in the following case: David N. Shapiro, M.D., St. Jude Children\'s Research Hospital: Based upon a report from St. Jude Children\'s Research Hospital as well as information obtained by the Office of Research Integrity (ORI) during its oversight review, ORI found that Dr. Shapiro, former faculty member, St. Jude Children\'s Research Hospital, engaged in scientific misconduct by falsifying the authorship of five publications listed in his biographical sketches in several National Institutes of Health (NIH) grant applications, including applications submitted to the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute of General Medical Sciences (NIGMS), the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), and the National Cancer Institute (NCI). Specifically, Dr. Shapiro listed himself as an author when he was not. Dr. Shapiro also fabricated data for Figures 5 and 7 in the following publication: Sublett, J.E., Jeon, I.S., & Shapiro, D.N. \`\`The aveolar rhabdomyosarcoma PAX3/FKHR fusion protein is a transcriptional activator.\'\' Oncogene 11:545-552, 1995. Dr. Shapiro has submitted a letter to Oncogene requesting retraction of these figures. Dr. Shapiro has accepted the ORI finding and has entered into a Voluntary Exclusion Agreement with ORI in which he has voluntarily agreed: (1) To exclude himself from serving in any advisory capacity to the Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant for a period of three (3) years, beginning on July 29, 1997; (2) To exclude himself from any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement transactions (e.g., grants and cooperative agreements) of the United States Government as defined in 45 CFR part 76 (Debarment Regulations) for a period of two (2) years, beginning on July 29, 1997; (3) That any institution that submits an application for PHS support for a research project on which Dr. Shapiro\'s participation is proposed or that uses him in any capacity on PHS supported research must concurrently submit a plan for supervision of his duties to the funding agency for approval for a period of one (1) year following the two (2) year exclusion. The supervisory plan must be designed to ensure the scientific integrity of Dr. Shapiro\'s research contribution. The institution also must submit a copy of the supervisory plan to ORI.
